Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Opus Genetics

Cell and Gene Therapy Today

Cell and Gene Therapy Today—June 18, 2026

This week’s Gene and Cell Therapy update highlights early clinical progress,…

Rare Disease news

Rare Diseases Today—May 7, 2026

This week’s Rare Diseases update highlights regulatory actions, gene therapy…

Cell_Gene_Therapy

Latest Cell and Gene Therapy News - Sept 17th to Oct 1st

Watch Our Video Summary Capturing Top Cell and Gene News from the Last Two…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - October 2nd 2025

Gene & Cell Therapy Update: eXmoor × Siam Bioscience Partnership, FDA Fast…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Obesity Today—June 23, 2026
LabGenius and LG Chem Advance Multispecific Antibody Partnership | Lucid Diligence Brief
Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Hematology Today—June 22, 2026
Oncology Today—June 22, 2026

Tags

AAVantgarde ALK5 AllRock Bio AML triplet Ascletis ASC47 Ateganosine Atla-cel AvenCell Therapeutics BANDIT Bempedoic Acid BRP cfDNA Childhood myopia CLEVER CNSide Diagnostics Crinetics Pharmaceuticals CS1 CUHK Ecnoglutide EMR integration Encoded Therapeutics ESMO 2025 Evolocumab (Repatha) GLP 1 Access IBS-C pediatric IKT-001 Large Language Models MedAdvisor Neonatal respiratory distress syndrome nutrition OpenAI Foundation pan-PPAR Pediatric Central Nervous System Cancer pertuzumab Pharmac Registries rxc007 Samjin Pharmaceutical Setidegrasib spatial biology SpectraWAVE STELLA trial STOBOCLO TEFCA VMX-C001

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Obesity Today—June 23, 2026
LabGenius and LG Chem Advance Multispecific Antibody Partnership | Lucid Diligence Brief
Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Hematology Today—June 22, 2026
Oncology Today—June 22, 2026

TAGS

AAVantgarde ALK5 AllRock Bio AML triplet Ascletis ASC47 Ateganosine Atla-cel AvenCell Therapeutics BANDIT Bempedoic Acid BRP cfDNA Childhood myopia CLEVER CNSide Diagnostics Crinetics Pharmaceuticals CS1 CUHK Ecnoglutide EMR integration Encoded Therapeutics ESMO 2025 Evolocumab (Repatha) GLP 1 Access IBS-C pediatric IKT-001 Large Language Models MedAdvisor Neonatal respiratory distress syndrome nutrition OpenAI Foundation pan-PPAR Pediatric Central Nervous System Cancer pertuzumab Pharmac Registries rxc007 Samjin Pharmaceutical Setidegrasib spatial biology SpectraWAVE STELLA trial STOBOCLO TEFCA VMX-C001

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy